CARLISI, Melania
 Distribuzione geografica
Continente #
NA - Nord America 1.782
EU - Europa 473
AS - Asia 86
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.346
Nazione #
US - Stati Uniti d'America 1.781
IT - Italia 279
CN - Cina 66
DE - Germania 41
BE - Belgio 28
IE - Irlanda 26
RU - Federazione Russa 22
GB - Regno Unito 21
FI - Finlandia 10
RO - Romania 10
UA - Ucraina 10
SE - Svezia 9
ES - Italia 4
FR - Francia 4
HK - Hong Kong 4
IN - India 4
BR - Brasile 3
KR - Corea 3
TR - Turchia 3
CH - Svizzera 2
GR - Grecia 2
NL - Olanda 2
PL - Polonia 2
AM - Armenia 1
BG - Bulgaria 1
CA - Canada 1
CO - Colombia 1
EU - Europa 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
SG - Singapore 1
Totale 2.346
Città #
Fairfield 345
Chandler 191
Ashburn 147
Woodbridge 145
Houston 124
Wilmington 116
Cambridge 114
Seattle 109
Ann Arbor 106
Palermo 67
Des Moines 50
Medford 38
Altamura 29
Brussels 27
Dublin 26
Princeton 24
Lawrence 21
Bremen 20
Boardman 17
San Diego 16
Nanjing 15
London 10
Shenyang 9
Milan 8
Beijing 7
Dearborn 7
Helsinki 7
Turin 7
Redwood City 6
Torino 6
Catania 5
Ningbo 5
Venice 5
Vicenza 5
Boydton 4
Central 4
Hebei 4
Jinan 4
Bad Dürrenberg 3
Changsha 3
Corropoli 3
Deiva Marina 3
Gavirate 3
Hangzhou 3
Jiaxing 3
Madrid 3
Napoli 3
Sciacca 3
Sciara 3
Taizhou 3
Trieste 3
Bari 2
Bergamo 2
Caltanissetta 2
Castelnuovo 2
Chicago 2
Foggia 2
Guangzhou 2
Hanover 2
Izmir 2
João Pessoa 2
Kumar 2
Lamezia Terme 2
Los Angeles 2
Lucera 2
Nanchang 2
Naples 2
Pescia 2
Phoenix 2
Porto San Giorgio 2
Romainville 2
Scafati 2
Seongnam 2
Tianjin 2
Warsaw 2
Alcamo 1
Baghdad 1
Barletta 1
Battipaglia 1
Belluno 1
Carpineto Romano 1
Cedar Knolls 1
Colturano 1
Como 1
Dallas 1
Edinburgh 1
Essen 1
Esslingen am Neckar 1
Fatima 1
Favara 1
Frankfurt Am Main 1
Groningen 1
Gunzenhausen 1
Gurgaon 1
Incisa 1
Jakarta 1
Kallo 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Totale 1.962
Nome #
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 252
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 166
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 161
Immunosenescence and lymphomagenesis 138
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) 137
Clinical disorders responsible for plasma hyperviscosity and skin complications 125
Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma 124
Aspetti emoreologici nella iperviscosità policitemica e sierica 122
Cardio-oncology in multiple myeloma: is it time for a specific focus? 119
Erythrocyte deformability and hemorheological profile in multiple myeloma 113
Red blood cell deformability in multiple myeloma 108
Lymphomas and thyroid: Bridging the gap 99
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 94
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 94
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 85
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 76
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 72
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 67
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 65
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 64
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 47
EVALUATION AND POTENTIAL ROLE OF BONE MARROW TISSUE-RESIDENT MEMORY T-CELLS IN PATIENTS WITH PLASMA CELL DYSCRASIAS 37
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 37
An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance 32
Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant 29
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors 14
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases 12
Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders 12
Leukocyte subtypes, gelatinases, and their tissue inhibitors in a group of subjects with asymptomatic carotid atherosclerosis 9
Uric acid and uric acid/creatinine ratio and their correlations with the hemorheological determinants in subjects with subclinical carotid atherosclerosis 8
Totale 2.518
Categoria #
all - tutte 7.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019169 0 0 1 4 5 11 12 9 4 17 45 61
2019/2020601 41 18 28 68 46 91 97 44 68 37 50 13
2020/2021581 23 34 102 122 54 23 35 33 44 52 25 34
2021/2022299 15 36 11 17 8 14 23 20 35 50 19 51
2022/2023631 52 98 9 76 70 85 57 50 63 22 40 9
2023/2024106 18 56 32 0 0 0 0 0 0 0 0 0
Totale 2.518